Do I still need to get a Pap (Papanicolau) smear after a hysterectomy (removal of the uterus)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pap Smear Screening After Hysterectomy

Women who have had a total hysterectomy with removal of the cervix for benign disease do not need Pap smear screening. 1

Decision Algorithm for Pap Testing After Hysterectomy

Total Hysterectomy (Cervix Removed)

  • For benign disease: No Pap smear screening needed 1
    • Efforts should be made to confirm through physical examination or pathology report that the cervix was completely removed 1
  • For history of CIN II/III or cervical cancer: Continue annual screening with vaginal cytology 1, 2
    • Screening should continue for at least 20 years after treatment 1, 2
    • Continue screening as long as the patient is in reasonably good health 1, 2

Subtotal/Supracervical Hysterectomy (Cervix Remains)

  • Continue regular cervical cancer screening according to age-appropriate guidelines 1
  • Screening should be performed every 2-3 years depending on age and risk factors 1

Rationale for Recommendations

Why Screening is Unnecessary After Total Hysterectomy for Benign Disease

  • Vaginal cancer is an uncommon gynecologic malignancy with an incidence rate of only 1-2/100,000/year 1
  • Abnormal vaginal cytologic smears are uncommon and rarely of clinical importance after benign hysterectomy 1
  • Studies estimate that almost 10 million women in the US are being screened unnecessarily after hysterectomy 3

Why Screening Should Continue in High-Risk Groups

  • Women with a history of CIN II/III or cervical cancer remain at increased risk for vaginal cancer 1, 2
  • Women with in-utero DES exposure are at increased risk for both cervical and vaginal cancer 1
  • Immunocompromised women (e.g., HIV infection) should continue screening due to higher risk 1

Common Pitfalls in Post-Hysterectomy Screening

  • Unnecessary screening: Despite guidelines recommending against it since 2003, many women continue to receive unnecessary Pap tests after total hysterectomy for benign disease 4, 5
  • Patient knowledge gaps: Only 67% of women correctly identified whether their cervix had been removed during hysterectomy and whether they needed future screening 6
  • Provider-initiated unnecessary testing: 32% of provider recommendations for Pap testing after hysterectomy are unnecessary 5
  • Patient-initiated unnecessary testing: Approximately one-fourth of unnecessary Pap tests after hysterectomy are initiated by patients without provider recommendations 5

Implementation of Guidelines

  • Confirm hysterectomy type and indication through medical records or physical examination 1
  • Document the absence of cervix and benign indication for hysterectomy in the medical record 1
  • For women with history of CIN II/III who had hysterectomy, follow-up cytology is recommended every 4-6 months initially 1, 2
  • Three documented, consecutive, technically satisfactory normal/negative vaginal cytology tests should be achieved within 18-24 months following hysterectomy for CIN II/III before modifying the screening schedule 2

Despite clear guidelines, screening rates remain high among women post-hysterectomy, with studies showing that 53-69% of women who have had a hysterectomy still report having had a Pap test within the past 3 years 3, 4. This represents a significant overuse of healthcare resources with minimal impact on decreasing cancer risk 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.